REVEAL Trial

Study / Research

A large clinical trial testing Anacetrapib, which showed a modest reduction in events but prompted discontinuation due to drug accumulation in adipose tissue.

Mentioned in 1 video

Videos Mentioning REVEAL Trial

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A large clinical trial testing Anacetrapib, which showed a modest reduction in events but prompted discontinuation due to drug accumulation in adipose tissue.